Skip to main content
Barrierer for at modtage opfølgende behandling blandt børnekræftoverlevere
Langvarig opfølgende plejeAlleArtikelEU-CAYAS-NET

Barrierer for at modtage opfølgende behandling blandt børnekræftoverlevere

Denne artikel identificerer de barrierer, som overlevende efter børnekræft kan møde, når det gælder langvarig opfølgning.

År:2023

Little is known on why adherence to follow-up care in childhood cancer survivors (CCS) is lacking. This study characterized barriers to adherence to follow-up care among CCS, identified sociodemographic correlates of barriers, and examined whether barriers to follow-up care relate to health-related quality of life. Adult CCS (N=84) were anonymously surveyed via REDCap using the Barriers to Care Questionnaire (BCQ) and the Quality of Life Scale-Cancer Survivor (QOL-CS).

Both descriptive and correlation analyses were conducted. The median BCQ total score was 88.5 (interquartile ranges: 78.4 to 95.7), with the greatest barriers reported in the Skills (eg, ease of navigating the healthcare system) and Pragmatism subscales (eg, cost). There was a statistically significant correlation between the BCQ total score and the QOL-CS total score (rs=0.47, P <0.0001) and the physical, psychological, and social QOL-CS subscales (all P ‘s<0.05).

The results found that barriers to follow-up care for CCS are mostly related to cost and appointment logistics, and that more barriers to care is associated with lower health-related quality of life among CCS. Identifying barriers to follow-up care is the first step in improving adherence, which would allow for earlier detection of late effects of cancer therapy and thereby result in reductions in morbidity and mortality.

Denne artikel giver kun informativ støtte og er ikke en erstatning for professionel lægelig rådgivning, diagnose eller behandling. Kontakt altid din læge, når du træffer medicinske beslutninger.

EU-CAYAS-NET project logo

Dette indhold blev skabt under projektet EU-CAYAS-NET, medfinansieret under EU4Health-programmet i 2022-2025 (tilskudsaftale nr. 101056918).

Diskussion & Spørgsmål

Bemærk: Kommentarer er kun til diskussion og afklaring. For medicinsk rådgivning, kontakt venligst en sundhedsprofessionel.

Skriv en kommentar

Minimum 10 tegn, maksimum 2000 tegn

Ingen kommentarer endnu

Bliv den første til at dele dine tanker!